Week Ahead: Senate committee to grill Big Pharma on drug prices

Modern Healthcare: Executives from seven Big Pharma companies will line up for questioning from the Senate Finance Committee in a hearing dubbed “Drug Pricing in America: A Prescription for Change, Part II.” Committee Chairman Chuck Grassley (R-Iowa) started the inquiry into drug prices last month. Grassley has supported efforts to crack down on manufacturer pay-to-delay tactics that stall generics from entering the market, as well as legislation to expedite generic drugs and biosimilars to market, which faces opposition from drug companies.

Read article

i360Gov Newsletters

The most significant government policy, business, and technology news and analysis delivered to your inbox.

Subscribe Now

Trending